Scotgold says CFO Duffy also to be interim CEO.NatWest, Edinburgh Uni, in innovation partnership.FirstGroup shares soar amid boost to buses, buyback.SNP launches search for £95k chief executive.Inward investment generates 8,500 Scots jobs.Abrdn £16bn fund tokenised by Archax in digital push.Weir Group prices £300m sustainability-linked notes.
Ace Aquatec investment as van der Kuyl becomes chair.UK to scrap N Sea windfall tax if prices keep falling.Sturgeon released without charge after arrest.Scots private sector expands for fourth straight month.Iomart revenue rises 12% to record £115.6m.School leavers in ‘positive destinations’ at 93.5%.Scots unemployment stays 3.1%, with UK on 3.8%.Gilbert says AssetCo ‘remains materially behind plan’.Scottish Canals ‘needs to improve financial reporting’.Record £762m equity investment for small Scots firms.“We have a very busy roadmap ahead and some incredibly exciting opportunities to take advantage of in 2023 and beyond”. “This round of investment is particularly crucial in helping us scale our offering and realising our vision of establishing Phlo as the market leader in the delivery of next-generation digital pharmacy services right across the UK. “The investment raised will help support our expansion across the UK and allow us to continue developing our Phlo Digital Pharmacy and Phlo Connect offering to improve healthcare outcomes. Sarwar said: “I would like to thank our existing and new investors for supporting Phlo’s mission as we enter into our next stage of growth. Phlo was founded by entrepreneur Nadeem Sarwar and is headquartered in Glasgow. “With Scottish Enterprise investment, the company can scale up operations and expand its services into new markets.” Kerry Sharp, Director of Entrepreneurship and Investment at Scottish Enterprise, said: “Phlo is a fantastic example of a growing innovative company that is helping patients and healthcare providers through its technology. “On behalf of Thairm Bio, I am proud to support Phlo and personally excited to see what the team achieves in the next stage of their journey.” “Phlo’s dedication to building innovative digital solutions that put patients and clinicians at the heart of what they do is key to driving positive change in the sector, empowering patients and healthcare providers. “Phlo’s drive and determination to improve patient access and healthcare outcomes at this pivotal moment for the pharmacy sector is impressive. Thairm Bio founder Mark Bamforth said: “Thairm Bio is delighted to lead this investment round, in partnership with a dedicated group of investors, and to support Phlo in their continued expansion across the UK. The round is led by Thairm Bio alongside support from Scottish Enterprise and a number of other high-profile angel investors.
Phlo digital pharmacy series#
Phlo’s Series A round is a combination of equity investment and the conversion of existing loan notes and follows the £2 million raised by Phlo in 2020 in the third largest recorded healthtech Crowdfunding campaign in Europe. This announcement comes as momentum behind digital transformation mounts in the pharmacy sector, powered by providers seeking solutions that will equip them to cope with supply chain fluctuations, spiralling operating costs, record workforce shortages, and the predicted closure of up to 3,000 high street pharmacy branches by 2024.
The funds will be used to expand the reach of Phlo Digital Pharmacy and to scale Phlo Connect, the digital infrastructure platform for healthcare providers. Glasgow-based digital pharmacy Phlo has closed a £10 million Series A round led by family office Thairm Bio.
0 kommentar(er)
